Skip to content

Randomized controlled trial to evaluate clinical safety and efficacy of oral immunotherapy with low dose of egg for children with egg allergy

Randomized controlled trial to evaluate clinical safety and efficacy of oral immunotherapy with low dose of egg for children with egg allergy - Small dose oral immunotherapy for liberating children from egg allergy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000005073
Enrollment
70
Registered
2011-02-13
Start date
2011-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Food hypersensitivity,Food allergy

Interventions

To take small amount of egg powder masked with corn powder once daily for 25-28 weeks To take corn powder as placebo once daily for 25-28 weeks

Sponsors

National Center for Child Health and Development
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Patients who keep complete elimination of egg from their diet 2)Patients who were confirmed as having egg allergy by double blind placebo controlled food challenge test 3)Egg white-specific IgE-positive patients 4)Patients whose family are cooperative enough to adhere to the protocol of this study

Exclusion criteria

Exclusion criteria: 1)Patients without immediate-type reaction to egg 2)Patients with uncontrolled asthma, atopic dermatitis or urticaria 3)Corn allergy patients 4)Patients who have treatment history or plan with omalizumab

Design outcomes

Primary

MeasureTime frame
The result of double -blind placebo controlled food challenge test of egg after 25-28 weeks intervention

Secondary

MeasureTime frame
1)The threshold change of egg allergen dose to provoke immediate reaction before and after this intervention 2)The change of egg specific antibody serum concentration before and after this intervention 3)Incidence of patients who experience allergic reaction due to adverse effect of this intervention 4)Onset number of allergic reaction due to adverse effect of this intervention in each case

Countries

Japan

Contacts

Public ContactYuki Tsumura

National Center for Child Health and Development Division of Allergy

smile-admin@umin.ac.jp03-3416-0181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026